Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$34.7M
+61.4% from 2023
Prescriptions
618
$56,215.64 per claim
Patients
53
52 prescribers
Total spending, 2024
$34.7M
$655,495.52 per patient
Medicare prescription drug plans paid $34.7M for Nexviazyme in 2024, for 618 prescriptions and refills to 53 patients (up 61.4% from 2023). The average cost per claim was $56,215.64.
New York had the highest Medicare cost for Nexviazyme in 2024: $4.6M for 103 claims, followed by North Carolina ($3.9M).
Priya Kishnani, pediatric medicine in Durham, NC, had the highest Medicare cost for Nexviazyme in 2024: 23 claims costing $1.9M.
Nexviazyme is made by Sanofi (SNY), listed in the Medicare spending data as Genzyme.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Priya Kishnani Durham, NC | Pediatric Medicine | 23 | Under 11 | $1.9M |
| Jessica Gold Great Neck, NY | Medical Genetics and Genomics | 62 | Under 11 | $1.9M |
| Chester B Whitley |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 25 | 248 | 26 | $15.1M |
| 2023 | 35 | 385 | 35 | $21.5M |
| 2024 | 52 | 618 | 53 | $34.7M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pediatric Medicine |
| 23 |
| Under 11 |
| $1.4M |
| Carolyn Jones Winfield, IL | Pathology | 26 | Under 11 | $1.4M |
| David J Cunningham Glens Falls, NY | Family Practice | 13 | Under 11 | $1.4M |
| Prasad V Kanneganti Columbus, OH | Neurology | 13 | Under 11 | $1.3M |
| Hani A Kushlaf Cincinnati, OH | Neurology | 13 | Under 11 | $1.2M |
| Jonathan H McKinnon Las Vegas, NV | Neurology | 13 | Under 11 | $1.1M |
| Ermal Aliu Hershey, PA | Pediatric Medicine | 12 | Under 11 | $999K |
| Madelena M Martin Sacramento, CA | Medical Genetics and Genomics | 26 | Under 11 | $931K |
| David F Clark Overland Park, KS | Neurology | 25 | Under 11 | $907K |
| Bassam Malo Fenton, MO | Neurology | 15 | Under 11 | $891K |
| Debra A O'Reilly Aurora, CO | Physician Assistant | 13 | Under 11 | $876K |
| Nicola Longo Los Angeles, CA | Pediatric Medicine | 13 | Under 11 | $835K |
| Mary-Alice Abbott Worcester, MA | Pediatric Medicine | 12 | Under 11 | $769K |
| Mary Jo K Voelpel Lake Orion, MI | Internal Medicine | 14 | Under 11 | $765K |
| Lisa R Jenike Springfield, MA | Nurse Practitioner | 15 | Under 11 | $745K |
| Roberta L Salveson Puyallup, WA | Nurse Practitioner | 13 | Under 11 | $739K |
| Carol J Trana Little Rock, AR | Physician Assistant | 26 | Under 11 | $707K |
| Darius J Adams Morristown, NJ | Family Practice | 15 | Under 11 | $674K |
| Alan E Lichtin Cleveland, OH | Hematology-Oncology | 11 | Under 11 | $646K |
| Nizar Chahin Portland, OR | Neurology | 20 | Under 11 | $596K |
| Perry B Shieh Los Angeles, CA | Neurology | 12 | Under 11 | $588K |
| Zachary S Spigelman Derry, NH | Hematology-Oncology | 11 | Under 11 | $559K |
| Kristin M Harter Wichita, KS | Nurse Practitioner | 12 | Under 11 | $524K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Genzyme SNY | 618 | $34.7M |